Health | WPN World People News

Community-based and individual-level prevention strategies are effective ways to reduce alcohol use among American Indian and other youth living in rural communities, according to a new study supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health. The National Institute on Drug Abuse also provided support for the study.

Percentage of young adults with diabetes developing complications from the disease.

WHO reaffirms the critical need for research and development (R&D) of new antibiotics to tackle the threat of drug-resistant tuberculosis (TB).

WHO, on February 27, published its first ever list of antibiotic-resistant "priority pathogens" – a catalogue of 12 families of bacteria that pose the greatest threat to human health.

Depression causes persistent sadness, a loss of interest in activities that you normally enjoy and an inability to carry out daily activities.

An investigational malaria vaccine has protected a small number of healthy U.S. adults from infection with a malaria strain different from that contained in the vaccine, according to a study. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, sponsored and co-conducted the Phase 1 clinical trial.

A participant receives an injection in an NIH trial examining a vaccine intended to provide broad protection against a range of mosquito-borne diseases.

On February 21, the World Bank hosted a roundtable discussion on the status of the Health Sector in Somalia. World Bank experts, Somali Government counterparts and international development partners convened around the newly released Country Health Status Note. “This Roundtable discussion harmonizes the health development approach used by country systems and other development actors. We are using this forum to let this approach inform future World Bank engagement in the Somali health sector,” said Hugh Riddell, Country Representative for the World Bank.

In older men with low testosterone, one year of testosterone treatment improved bone density and corrected anemia of both known and unknown causes, but also increased the volume of coronary artery plaque, according to results reported from the Testosterone Trials (T Trials). Testosterone treatment had no effect on memory or other cognitive function. The results are reported in two journals coming out this week.